Lisinopril side effects kidney
Pro Research Analysisby 
Searched over 200M research papers
Lisinopril Side Effects on Kidney Function
Introduction to Lisinopril and Kidney Function
Lisinopril, an angiotensin-converting enzyme (ACE) inhibitor, is commonly prescribed for managing hypertension and heart failure. It is also used to protect kidney function in patients with diabetic nephropathy. However, its effects on the kidneys, particularly potential side effects, are a critical area of study.
Impact on Diabetic Nephropathy
Comparative Studies with Other Antihypertensives
Several studies have compared the effects of lisinopril with other antihypertensive medications on kidney function in diabetic patients. In hypertensive type 1 diabetic patients with diabetic nephropathy, lisinopril significantly reduced albuminuria compared to nisoldipine, a calcium antagonist, although both drugs showed similar long-term benefits on kidney function . Similarly, in hypertensive non-insulin-dependent diabetes mellitus (NIDDM) patients, lisinopril reduced urinary albumin excretion more effectively than atenolol, a beta-blocker, despite both drugs showing similar effects on the decline of glomerular filtration rate (GFR) Nielsen1997Nielsen1994.
Long-Term Renal Protection
Lisinopril has demonstrated a renoprotective effect in various studies. For instance, in patients with mild proteinuric non-diabetic nephropathies, lisinopril slowed the progression of renal insufficiency more effectively than other antihypertensive agents . Additionally, in normotensive patients with insulin-dependent diabetes and normoalbuminuria or microalbuminuria, lisinopril slowed the progression of renal disease, particularly in those with microalbuminuria .
Effects in Renal Transplant Recipients
In renal transplant recipients with hypertension and proteinuria, lisinopril effectively lowered systemic blood pressure and reduced proteinuria without significantly affecting serum creatinine levels or GFR . However, another study found that nifedipine, a calcium channel blocker, improved kidney transplant function more than lisinopril over a two-year period .
Combination Therapy and Safety Concerns
Combining lisinopril with other medications has shown mixed results. For example, combining lisinopril with semaglutide, a GLP-1 receptor agonist, in a mouse model of diabetic kidney disease resulted in further improvements in blood pressure, albuminuria, and glomerulosclerosis compared to semaglutide alone . However, a study combining lisinopril with losartan, an angiotensin-receptor blocker, in patients with type 2 diabetes and diabetic nephropathy was stopped early due to increased risks of hyperkalemia and acute kidney injury .
Conclusion
Lisinopril is effective in reducing albuminuria and slowing the progression of kidney disease in diabetic and non-diabetic patients. However, its use, particularly in combination with other medications, must be carefully monitored due to potential risks such as hyperkalemia and acute kidney injury. Further research is needed to optimize its use and ensure patient safety.
Sources and full results
Most relevant research papers on this topic
Long-term renoprotective effect of nisoldipine and lisinopril in type 1 diabetic patients with diabetic nephropathy.
Both lisinopril and nisoldipine have similar long-term renoprotective effects in hypertensive type 1 diabetic patients with diabetic nephropathy.
Effect of Lisinopril on the progression of renal insufficiency in mild proteinuric non-diabetic nephropathies.
Lisinopril has a specific renoprotective effect in addition to blood pressure control in patients with mild proteinuria, slowing the progression of non-diabetic chronic renal diseases.
DOI